Collegium Pharmaceutical Inc. (COLL)
NASDAQ · Healthcare
Collegium Pharmaceutical Inc. Gross Profit 2016–2025
Collegium Pharmaceutical Inc. annual/quarterly gross profit history and growth rate from 2016 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Collegium Pharmaceutical Inc. gross profit for the quarter ending March 31, 2026 was 117.2 M, a 20.47% increase year-over-year.
- Collegium Pharmaceutical Inc. gross profit for the twelve months ending March 31, 2026 was 452.1 M, a 25.81% increase year-over-year.
- Collegium Pharmaceutical Inc. annual gross profit for 2025 was 463.3 M, a 22.77% increase from 2024.
- Collegium Pharmaceutical Inc. annual gross profit for 2024 was 377.3 M, a 15.69% increase from 2023.
- Collegium Pharmaceutical Inc. annual gross profit for 2023 was 326.2 M, a 55.70% increase from 2022.
- Collegium Pharmaceutical Inc. annual gross profit for 2022 was 209.5 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Collegium Pharmaceutical Inc. Gross Profit — FAQ
Collegium Pharmaceutical Inc. (COLL) gross profit over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Collegium Pharmaceutical Inc.'s gross profit?
Collegium Pharmaceutical Inc. (COLL) reported gross profit of $463M for fiscal 2025.
Where can I see COLL's gross profit history?
The chart and table above show Collegium Pharmaceutical Inc.'s gross profit by year and by quarter, including the growth rate.